Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fate Therapeutics (FATE) Change in Cash (2016 - 2025)

Historic Change in Cash for Fate Therapeutics (FATE) over the last 14 years, with Q3 2025 value amounting to -$627000.0.

  • Fate Therapeutics' Change in Cash rose 8415.87% to -$627000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 82346.67%. This contributed to the annual value of -$10.8 million for FY2024, which is 4483.68% up from last year.
  • Fate Therapeutics' Change in Cash amounted to -$627000.0 in Q3 2025, which was up 8415.87% from -$3.7 million recorded in Q2 2025.
  • Fate Therapeutics' 5-year Change in Cash high stood at $79.5 million for Q1 2024, and its period low was -$84.4 million during Q2 2024.
  • In the last 5 years, Fate Therapeutics' Change in Cash had a median value of -$3.7 million in 2025 and averaged -$6.9 million.
  • Per our database at Business Quant, Fate Therapeutics' Change in Cash tumbled by 410814.92% in 2021 and then skyrocketed by 51139.13% in 2024.
  • Fate Therapeutics' Change in Cash (Quarter) stood at $4.4 million in 2021, then plummeted by 571.5% to -$20.8 million in 2022, then surged by 141.12% to $8.5 million in 2023, then plummeted by 121.71% to -$1.9 million in 2024, then skyrocketed by 66.16% to -$627000.0 in 2025.
  • Its last three reported values are -$627000.0 in Q3 2025, -$3.7 million for Q2 2025, and $8.9 million during Q1 2025.